Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21147694 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer (CLEOPATRA)
Condition: Metastatic Breast Cancer
Interventions: Drug: Pertuzumab;   Drug: Placebo;   Drug: Trastuzumab;   Drug: Docetaxel

Indicates status has not been verified in more than two years